Is the treatment of hyperlipidemia as secondary prevention adequate in different age groups in Israel?

Israel Medical Association Journal

Volumn 5, Issue 7, 2003, Pages 479-481

  Shilo, Lotan ^a,b   Feldman, Jacob ^a,b   Gendlman, Veronica ^a,b   Shenkman, Louis ^a,b   Berner, Yitshal N ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coronary heart disease; Elderly; Hyperlipidemia; Secondary prevention

Indexed keywords

DISEASES; LIPIDS; PATIENT TREATMENT;

CORONARY HEART DISEASES;

CARDIOLOGY;

ANTILIPEMIC AGENT; BEZAFIBRATE; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DEVELOPED COUNTRY; DIET THERAPY; ELDERLY CARE; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; ISRAEL; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT PLANNING; ATTITUDE TO HEALTH; BLOOD; CAREGIVER; CLINICAL PRACTICE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; HEALTH CARE QUALITY; HOSPITALIZATION; MIDDLE AGED; OUTCOME ASSESSMENT; TIME;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; CAREGIVERS; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; ISRAEL; LIFE STYLE; LIPIDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0042567243     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Vital and Health Statistics. National Hospital Discharge Survey: Annual Summary, 1994. Series 13: Data from the National Health Care Survey No. 128. DHHS Publication No (PHS) 97-1789. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Washington DC, 1995.
2. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and broad range of initial cholesterol values. N Engl J Med 1998;339:1349-57.
4. Kagansky N, Levy S, Berner Y, Rimon E, Knobler H. Cholesterol lowering in the older population: Time for reassessment? Q J Med 2001;94:457-63.
5. Miettinen TA, Pyörälä K, Olsson AG, et al. Cholesterol lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997;96:4211-18.
6. Hall KM, Luepker RV. Is hypercholesterolemia a risk factor and should it be treated in the elderly? Am J Health Promot 2000;14:347-56.
7. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II, updated 2001). JAMA 2001;285:2486-97.
8. Majumdar SR, Gurwits JH, Soumerai SB. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease. J Gen Intern Med 1999;14 (12):711-17.
9. Xhignesse M, Laplante P, Grant AM, et al. Antiplatelet and lipid-lowering therapies for the secondary prevention of cardiovascular disease: Are we doing enough? Can J Cardiol 1999;15:185-9.
10. McBride P, Schrott HG, Plane MB, Underbakke G, Brown RL. Primary care adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med 1998;158:1238-44.
11. Harris T, Cook EF, Kannel WB, Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older: The Framingham Heart Study. J Am Geriatr Soc 1988;36:1023-8.
12. Hippisley CJ, Pringle M, Crown N, Meal A, Wynn A. Sex inequalities in ischemic heart disease in general practice: Cross sectional survey. Br Med J 2001;322:832-9.
13. Grover SA, Paquet S, Levinton C, Coupal L, Zowall H. Estimating the benefits of modifying risk factors of cardiovascular disease: A comparison of primary vs. secondary prevention. Arch Intern Med 1998;158(6):655-62.